SAFFRON GROUP PRACTICE — All Prescriptions & Medications — Page 6
Practice Code: C82046 | LEICESTER, LE2 6UL
Showing results 251-300 of 781
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Etoricoxib | 170 | 4,860 | £1.3K | +111.0% ▲ |
| Ticagrelor | 168 | 9,996 | £9.7K | +97.6% ▲ |
| Perindopril erbumine | 167 | 5,688 | £406 | -68.5% ▼ |
| Vortioxetine | 167 | 3,696 | £3.5K | +140.6% ▲ |
| Timolol and bimatoprost | 165 | 1,305 | £3.0K | +8.7% ▲ |
| Haloperidol | 163 | 7,112 | £6.5K | +242.2% ▲ |
| Ropinirole hydrochloride | 159 | 7,294 | £4.4K | +49.7% ▲ |
| Tolterodine | 159 | 7,728 | £952 | +6.9% ▲ |
| Chloramphenicol | 159 | 1,420 | £829 | +38.9% ▲ |
| Theophylline | 158 | 9,044 | £4.6K | +89.0% ▲ |
| Triamcinolone acetonide | 157 | 157 | £217 | +109.9% ▲ |
| Insulin Lispro | 156 | 1,260 | £10.2K | +103.9% ▲ |
| 156 | 29.5K | £1.4K | +53.6% ▲ | |
| Fluconazole | 155 | 1,482 | £574 | +100.5% ▲ |
| Azathioprine | 155 | 10.6K | £327 | +43.0% ▲ |
| Amiodarone hydrochloride | 152 | 4,452 | £241 | +135.6% ▲ |
| Hydrocortisone | 149 | 11.6K | £7.2K | +76.5% ▲ |
| Valproic acid | 146 | 11.4K | £3.2K | +67.8% ▲ |
| 141 | 17.5K | £933 | +102.1% ▲ | |
| Dalteparin sodium | 140 | 1,914 | £12.4K | +747.3% ▲ |
| Clarithromycin | 140 | 3,384 | £606 | -42.9% ▼ |
| Tranexamic acid | 139 | 7,545 | £524 | +64.0% ▲ |
| Fentanyl | 138 | 1,390 | £8.1K | +34.7% ▲ |
| Sitagliptin | 137 | 3,892 | £276 | -64.9% ▼ |
| Terbinafine hydrochloride | 136 | 5,118 | £2.1K | +120.0% ▲ |
| Betamethasone esters | 136 | 8,910 | £945 | +125.4% ▲ |
| 135 | 2,170 | £561 | +213.1% ▲ | |
| Pancreatin | 134 | 49.9K | £14.5K | +20.5% ▲ |
| Metronidazole | 134 | 2,385 | £122 | +103.9% ▲ |
| Ursodeoxycholic acid | 128 | 15.2K | £5.4K | +93.4% ▲ |
| Pizotifen malate | 128 | 5,726 | £265 | +55.3% ▲ |
| Adapalene and benzoyl peroxide | 128 | 6,465 | £2.8K | +139.7% ▲ |
| Goserelin acetate | 125 | 125 | £21.8K | +183.7% ▲ |
| 125 | 59.9K | £625 | +37.1% ▲ | |
| Rabeprazole sodium | 124 | 5,460 | £751 | +140.4% ▲ |
| Other individually formulated bought in preparations | 124 | 4,134 | £1.4K | +279.5% ▲ |
| 124 | 5,478 | £2.0K | +81.0% ▲ | |
| Risedronate sodium | 123 | 1,144 | £614 | +1.4% vs avg |
| Ivabradine | 121 | 6,048 | £921 | +27.3% ▲ |
| Dosulepin hydrochloride | 121 | 8,421 | £1.8K | +113.7% ▲ |
| 120 | 291 | £2.6K | +331.3% ▲ | |
| Hypromellose | 119 | 1,520 | £189 | -10.2% ▼ |
| Carbomer 940/980 | 116 | 2,360 | £562 | -23.8% ▼ |
| Omega-3-acid ethyl esters | 115 | 6,300 | £3.0K | +444.2% ▲ |
| Rizatriptan | 115 | 1,029 | £2.7K | +93.5% ▲ |
| Urea | 115 | 40.4K | £1.4K | +72.1% ▲ |
| Clonidine hydrochloride | 112 | 10.1K | £989 | +109.9% ▲ |
| Bempedoic acid | 111 | 3,304 | £6.2K | +238.6% ▲ |
| Bezafibrate | 110 | 5,452 | £970 | +104.2% ▲ |
| Lofepramine hydrochloride | 110 | 8,288 | £3.5K | +267.7% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.